Flavio Caprioli

Associate professor

Università degli Studi di Torino

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Flavio Caprioli is an Associate Professor at Università degli Studi di Milano in Italy. His research focuses on inflammatory bowel diseases, with particular attention to fecal microbiota transplantation, treatment strategies, and patient care management. Recent publications include studies on the impact of SARS-CoV-2 on patients with inflammatory bowel diseases, as well as assessments of disability in this patient population. He contributes to advancing knowledge in gastroenterology through pragmatic trial designs and epidemiological insights.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Glen Doherty

UCD Full Clinical Professor

Dublin City University

IRELAND

View details

Javier Pérez Gisbert

Tenure Professor

Universidad Autónoma de Madrid

SPAIN

View details

Detlef Schuppan

institute of translational immunology and research center for immune therapy university medical center mainz germany

GERMANY

View details

Antonio Ciardi

Researcher, Aggregate Professor Anatomic Pathology

Università degli Studi di Roma La Sapienza Facoltà di Medicina e Odontoiatria

ITALY

View details

Alessandro Armuzzi

Humanitas University

ITALY

View details

Julien Kirchgesner

Associate Professor

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Flavio Caprioli

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Liver Involvement in Celiac Disease and Immune‐Mediated Diseases of the Small Bowel

Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference

Curing inflammatory bowel diseases: breaking the barriers of current therapies– emerging strategies for a definitive treatment

Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease

Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study

Response to Wei-Zhen Tang et al

Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus

Environmental Protective and Risk Factors in an At-Risk Population of Subsequent Crohn’s Disease

Letter of Reply to “Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association”

Determinants of patient trust in gastroenterology televisits: Results of machine learning analysis

Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak

Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 10.1038/s41379-020-0497-0)

Histopathology of inflammatory bowel disease — Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC)

PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability

Separation of Low-Versus High-grade Crohn's Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis

Collaborators (6)

Glen Doherty

Javier Pérez Gisbert

Detlef Schuppan

Antonio Ciardi

Alessandro Armuzzi

Julien Kirchgesner

Make your next move.